Document is current
Any future updates will be listed below
-
Authors
Melsen, Janine E. https://orcid.org/0000-0001-5322-7194
van Ostaijen-ten Dam, Monique M.
van den Akker, Erik B. https://orcid.org/0000-0002-7693-0728
Welters, Marij J. P. https://orcid.org/0000-0002-9809-8266
Heezen, Kim C.
Pico-Knijnenburg, Ingrid https://orcid.org/0000-0001-6325-8314
Kolijn, P. Martijn
Bredius, Robbert G. M. https://orcid.org/0000-0001-8151-1539
van Doorn, Remco
Langerak, Anton W. https://orcid.org/0000-0002-2078-3220
Schilham, Marco W. https://orcid.org/0000-0003-4391-6003
Lankester, Arjan C. https://orcid.org/0000-0002-6703-2993
-
Funding
Funding for this research was provided by:
Leids Universitair Medisch Centrum
Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Stichting Zeldzame Ziekten Fonds
- License Information
-
More Information
Article History
Received: 2 February 2022
Accepted: 25 April 2022
First Online: 9 May 2022
Declarations
:
: With approval of the institutional review board (protocols P00.068, P01.028 and B17.001), blood (UPN1, healthy donor/controls) and skin samples (UPN1) were analyzed.
: Informed consent was obtained from the patient and healthy controls for study participation.
: This consent was obtained with the consent to participate.
: The authors declare no competing interests.
